Copyright
©The Author(s) 2023.
World J Meta-Anal. Apr 18, 2023; 11(4): 92-101
Published online Apr 18, 2023. doi: 10.13105/wjma.v11.i4.92
Published online Apr 18, 2023. doi: 10.13105/wjma.v11.i4.92
Figure 1 Alteration of lipocalin-2 levels in different diseases.
Lipocalin-2 levels increase in all except a few cancers where its levels are found to decrease. AKI: Acute kidney injury; CKD: Chronic kidney disease; CVD: Cardiovascular disease; DM: Diabetes mellitus.
- Citation: Dahiya K, Prashant P, Dhankhar R, Dhankhar K, Kumar S, Vashist S. Lipocalin-2 as a biomarker for diabetic nephropathy. World J Meta-Anal 2023; 11(4): 92-101
- URL: https://www.wjgnet.com/2308-3840/full/v11/i4/92.htm
- DOI: https://dx.doi.org/10.13105/wjma.v11.i4.92